[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CNS Specific Antisense Oligonucleotides Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: C17D77F2496FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of CNS Specific Antisense Oligonucleotides in Global, including the following market information:

Global CNS Specific Antisense Oligonucleotides Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global CNS Specific Antisense Oligonucleotides market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CNS Specific Antisense Oligonucleotides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CNS Specific Antisense Oligonucleotides Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global CNS Specific Antisense Oligonucleotides Market Segment Percentages, By Type, 2020 (%)
  • Polyneuropathy Treatment
  • Spinal Muscular Atrophy (SMA) Treatment
  • Huntington’s Disease Treatment
China CNS Specific Antisense Oligonucleotides Market, By Application, 2016-2021, 2022-2027 ($ millions)

China CNS Specific Antisense Oligonucleotides Market Segment Percentages, By Application, 2020 (%)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global CNS Specific Antisense Oligonucleotides Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global CNS Specific Antisense Oligonucleotides Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total CNS Specific Antisense Oligonucleotides Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total CNS Specific Antisense Oligonucleotides Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Akcea Therapeutics, Inc.
  • Ionis Pharmaceuticals Inc.
  • Biogen Inc.
  • Sarepta Therapeutics
  • Wave Life Sciences Ltd.
  • Dynacure
  • ProQR Therapeutics N.V.
  • Stroke Therapeutic Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CNS Specific Antisense Oligonucleotides Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CNS Specific Antisense Oligonucleotides Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDES OVERALL MARKET SIZE

2.1 Global CNS Specific Antisense Oligonucleotides Market Size: 2021 VS 2027
2.2 Global CNS Specific Antisense Oligonucleotides Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CNS Specific Antisense Oligonucleotides Players in Global Market
3.2 Top Global CNS Specific Antisense Oligonucleotides Companies Ranked by Revenue
3.3 Global CNS Specific Antisense Oligonucleotides Revenue by Companies
3.4 Top 3 and Top 5 CNS Specific Antisense Oligonucleotides Companies in Global Market, by Revenue in 2020
3.5 Global Companies CNS Specific Antisense Oligonucleotides Product Type
3.6 Tier 1, Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Players in Global Market
  3.6.1 List of Global Tier 1 CNS Specific Antisense Oligonucleotides Companies
  3.6.2 List of Global Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global CNS Specific Antisense Oligonucleotides Market Size Markets, 2021 & 2027
  4.1.2 Polyneuropathy Treatment
  4.1.3 Spinal Muscular Atrophy (SMA) Treatment
  4.1.4 Huntington’s Disease Treatment
4.2 By Type - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
  4.2.1 By Type - Global CNS Specific Antisense Oligonucleotides Revenue, 2016-2021
  4.2.2 By Type - Global CNS Specific Antisense Oligonucleotides Revenue, 2022-2027
  4.2.3 By Type - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CNS Specific Antisense Oligonucleotides Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
  5.2.1 By Application - Global CNS Specific Antisense Oligonucleotides Revenue, 2016-2021
  5.2.2 By Application - Global CNS Specific Antisense Oligonucleotides Revenue, 2022-2027
  5.2.3 By Application - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global CNS Specific Antisense Oligonucleotides Market Size, 2021 & 2027
6.2 By Region - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
  6.2.1 By Region - Global CNS Specific Antisense Oligonucleotides Revenue, 2016-2021
  6.2.2 By Region - Global CNS Specific Antisense Oligonucleotides Revenue, 2022-2027
  6.2.3 By Region - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America CNS Specific Antisense Oligonucleotides Revenue, 2016-2027
  6.3.2 US CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.3.3 Canada CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.3.4 Mexico CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, 2016-2027
  6.4.2 Germany CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.3 France CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.4 U.K. CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.5 Italy CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.6 Russia CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.7 Nordic Countries CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.4.8 Benelux CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, 2016-2027
  6.5.2 China CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.5.3 Japan CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.5.4 South Korea CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.5.5 Southeast Asia CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.5.6 India CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America CNS Specific Antisense Oligonucleotides Revenue, 2016-2027
  6.6.2 Brazil CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.6.3 Argentina CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, 2016-2027
  6.7.2 Turkey CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.7.3 Israel CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.7.4 Saudi Arabia CNS Specific Antisense Oligonucleotides Market Size, 2016-2027
  6.7.5 UAE CNS Specific Antisense Oligonucleotides Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Akcea Therapeutics, Inc.
  7.1.1 Akcea Therapeutics, Inc. Corporate Summary
  7.1.2 Akcea Therapeutics, Inc. Business Overview
  7.1.3 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.1.4 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.1.5 Akcea Therapeutics, Inc. Key News
7.2 Ionis Pharmaceuticals Inc.
  7.2.1 Ionis Pharmaceuticals Inc. Corporate Summary
  7.2.2 Ionis Pharmaceuticals Inc. Business Overview
  7.2.3 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.2.4 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.2.5 Ionis Pharmaceuticals Inc. Key News
7.3 Biogen Inc.
  7.3.1 Biogen Inc. Corporate Summary
  7.3.2 Biogen Inc. Business Overview
  7.3.3 Biogen Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.3.4 Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.3.5 Biogen Inc. Key News
7.4 Sarepta Therapeutics
  7.4.1 Sarepta Therapeutics Corporate Summary
  7.4.2 Sarepta Therapeutics Business Overview
  7.4.3 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.4.4 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.4.5 Sarepta Therapeutics Key News
7.5 Wave Life Sciences Ltd.
  7.5.1 Wave Life Sciences Ltd. Corporate Summary
  7.5.2 Wave Life Sciences Ltd. Business Overview
  7.5.3 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.5.4 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.5.5 Wave Life Sciences Ltd. Key News
7.6 Dynacure
  7.6.1 Dynacure Corporate Summary
  7.6.2 Dynacure Business Overview
  7.6.3 Dynacure CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.6.4 Dynacure CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.6.5 Dynacure Key News
7.7 ProQR Therapeutics N.V.
  7.7.1 ProQR Therapeutics N.V. Corporate Summary
  7.7.2 ProQR Therapeutics N.V. Business Overview
  7.7.3 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.4.4 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.7.5 ProQR Therapeutics N.V. Key News
7.8 Stroke Therapeutic Inc.
  7.8.1 Stroke Therapeutic Inc. Corporate Summary
  7.8.2 Stroke Therapeutic Inc. Business Overview
  7.8.3 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
  7.8.4 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue in Global (2016-2021)
  7.8.5 Stroke Therapeutic Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. CNS Specific Antisense Oligonucleotides Market Opportunities & Trends in Global Market
Table 2. CNS Specific Antisense Oligonucleotides Market Drivers in Global Market
Table 3. CNS Specific Antisense Oligonucleotides Market Restraints in Global Market
Table 4. Key Players of CNS Specific Antisense Oligonucleotides in Global Market
Table 5. Top CNS Specific Antisense Oligonucleotides Players in Global Market, Ranking by Revenue (2019)
Table 6. Global CNS Specific Antisense Oligonucleotides Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global CNS Specific Antisense Oligonucleotides Revenue Share by Companies, 2016-2021
Table 8. Global Companies CNS Specific Antisense Oligonucleotides Product Type
Table 9. List of Global Tier 1 CNS Specific Antisense Oligonucleotides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2022-2027
Table 30. Akcea Therapeutics, Inc. Corporate Summary
Table 31. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product Offerings
Table 32. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 33. Ionis Pharmaceuticals Inc. Corporate Summary
Table 34. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product Offerings
Table 35. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 36. Biogen Inc. Corporate Summary
Table 37. Biogen Inc. CNS Specific Antisense Oligonucleotides Product Offerings
Table 38. Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 39. Sarepta Therapeutics Corporate Summary
Table 40. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product Offerings
Table 41. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 42. Wave Life Sciences Ltd. Corporate Summary
Table 43. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product Offerings
Table 44. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 45. Dynacure Corporate Summary
Table 46. Dynacure CNS Specific Antisense Oligonucleotides Product Offerings
Table 47. Dynacure CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 48. ProQR Therapeutics N.V. Corporate Summary
Table 49. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product Offerings
Table 50. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)
Table 51. Stroke Therapeutic Inc. Corporate Summary
Table 52. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Product Offerings
Table 53. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. CNS Specific Antisense Oligonucleotides Segment by Type
Figure 2. CNS Specific Antisense Oligonucleotides Segment by Application
Figure 3. Global CNS Specific Antisense Oligonucleotides Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CNS Specific Antisense Oligonucleotides Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global CNS Specific Antisense Oligonucleotides Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CNS Specific Antisense Oligonucleotides Revenue in 2020
Figure 8. By Type - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 9. By Application - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 10. By Region - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 11. By Country - North America CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 12. US CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 13. Canada CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 16. Germany CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 17. France CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 19. Italy CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 20. Russia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 24. China CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 25. Japan CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 28. India CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 30. Brazil CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue Market Share, 2016-2027
Figure 33. Turkey CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 34. Israel CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 36. UAE CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2016-2027
Figure 37. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Dynacure CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications